Glue inside the cell: Ubiquitin builds up an immune response
Ubiquitin is a small protein, which can be attached to other cellular
proteins, a process known as ubiquitination. Discoveries in the 1980 th
on a key function of ubiquitination in the regulation of protein
degradation where awarded with the Nobel Prize for chemistry in 2004. A
study headed by the Junior Group of Dr. Daniel Krappmann (GSF - National
Research Center for Environment and Health, Institute of Toxicology) in
collaboration with Dr. J�rgen Ruland (TU Munich) and Dr. Claus Scheidereit ( Max-Delbr�ck-Center , Berlin ) now reports a novel finding
about ubiquitination as a key event for the activation of an immune
response. (see below).
The acquired immune response is triggered after specific engagement of
foreign peptides (antigens) by receptor molecules on white blood cell
(lymphocytes). Cellular signaling pathways are responsible for the
activation of lymphocytes. Krappmann and co-workers present evidence,
that in T cells, which constitute a subgroup of lymphocytes, ubiquitin
is attached to the Malt1 protein in response to antigen stimulation.
Malt1 is part of the CBM (Carma1-Bcl10-Malt1) complex that constitutes
a crucial switch for the activation of the immune defense. Using
biochemical, molecular and genetic techniques the scientists could
prove that this novel Malt1 ubiquitination is an essential step in the
regulation of T cell activation.
�Mechanistically, ubiquitin is virtually acting as all-purpose glue
that links different protein components inside the cell�, Krappmann explains. �However, ubiquitination provides an important advantage
compared to conventional adhesives: It is reversible, meaning that the
associations can be resolved�.
This process of de-ubiquitination is constantly happening in cells and
it could contribute to prevent an over-shooting activation of T cells.
Unopposed lymphocyte activity is responsible for many chronic diseases,
autoimmunity or even lymphoma development. Future work must address
the status of Malt1 ubiquitination under pathological conditions, for
instance in Malt1 dependent lymphomas. By this the scientists hope to
demonstrate the potential of targeting the ubiquitin system for the
development of novel therapeutic approaches.
